Drug addiction, substance-related disorders, opioid maintenance treatment, HIV.
Annie Talbot has over 15 years of clinical research experience - ranging from clinical trials to field-based intervention studies in Africa. She has been a co-investigator on a number of Phase III clinical trials for antiretroviral drugs both in Quebec and as part of her Research Fellowship at Stanford University. She was the lead Investigator for community-based epidemiological studies in Rwanda which led to a first author publication in AIDS Education Prevention Journal in 2013 as well as a community-based intervention study that targeted alcohol ad drug use in Rwandan youth. While at Stanford she was a co- investigator on a epidemiologic evaluation of drug resistance in highly treated HIV-Infected adults, which also led to a first author publication in Antimicrobial Agents and Chemotherapy in 2010. Since she joined the CRCHUM, she has been involved in clinical research projects on addiction treatment, the Optima project, Cannabidiol Project, among others.